Business
Press Release Dec 22 2025
Granules India Limited has informed the Exchange regarding a press release dated December 22, 2025, titled "Granules Pharmaceuticals Inc. Receives FDA Tentative Approval for Generic Amphetamine Extended-Release Orally Disintegrating Tablets (ADZENYS XR-ODT®)".
About this update from Granules India Limited
[{"type":"text","content":" Granules India Limited has informed the Exchange regarding a press release dated December 22, 2025, titled \"Granules Pharmaceuticals Inc. Receives FDA Tentative Approval for Generic Amphetamine Extended-Release Orally Disintegrating Tablets (ADZENYS XR-ODT®)\". View Attachment","length":407,"tagName":"div"}]